In a groundbreaking advancement that holds transformative potential for the treatment of chronic inflammatory diseases, scientists have engineered exosome nanovesicles…
Credit: Extreme Media/Getty Images Nucleus Biologics launched the Krakatoa® K500, which the company says is the first bioreactor-scale, pod-based media…